Skip to main content
. Author manuscript; available in PMC: 2013 Jun 21.
Published in final edited form as: J Chem Inf Model. 2012 Mar 26;52(4):1046–1060. doi: 10.1021/ci200620h

Figure 3.

Figure 3

Protein pharmacophores identified in the active site of HIVPR (left) and the interaction between the cyclic sulfamide HIVPR inhibitor 1AJV:NMB and the binding site residues. The binding site residues are shown as grey sticks. The pharmacophore features are color-coded as described in Figure 2.